Health care professionals

Refer a patient for transplant

The Fred Hutch Bone Marrow Transplant (BMT) Program at Seattle Cancer Care Alliance (SCCA) consistently ranks among the country’s top transplant centers. Our doctors have performed more transplants than any other institution in the world.

Partnering with referring doctors and staying in close contact about our shared patients leads to the best transplant results. Together, we make more cures possible.

Bone marrow The soft, spongy material in the center of your bones that produces all your blood cells, such as white blood cells, red blood cells and platelets.

Doc-To-Doc Consultation

Call (800) 804-8824 or (206) 606-1024 to setup a telephone consultation with a transplant physician or make an appointment for your patient to see one of our transplant specialists.

Why choose SCCA for a bone marrow transplant?

Excellent transplant outcomes

Ours is one of only five transplant centers nationwide whose patients achieved higher-than-expected survival rates for the last four consecutive years, according to a study by the Center for International Blood and Marrow Transplant Research. Doctors at the Fred Hutch BMT Program at SCCA have performed more than 15,000 bone marrow transplants — more than any other institution in the world.

SCCA is the leading cancer treatment center in the region and among the top nationally, according to U.S. News & World Report.

Bone marrow The soft, spongy material in the center of your bones that produces all your blood cells, such as white blood cells, red blood cells and platelets. Bone marrow transplant The process of treating disease with high doses of chemotherapy, radiation therapy or both. Bone marrow or peripheral blood stem cells are given after treatment to help the body make more blood cells. The process of treating disease with high doses of chemotherapy, radiation therapy or both. Because this treatment destroys the bone marrow’s ability to produce blood cells, bone marrow or peripheral blood stem cells are given after treatment to help the body make more blood cells.

Promising options for more candidates

More patients are eligible for transplant than ever before, thanks to the wide range of options available at SCCA, including innovations like:

Reduced-intensity (non-myeloablative) conditioning for older patients or those with comorbidities
Cord blood, minimally mismatched and haploidentical transplants so nearly everyone has a donor
Transplant clinical trials testing the latest regimens

Clinical trial A type of research study that tests how well new medical approaches work in people. These studies test new methods of screening, prevention, diagnosis or treatment of a disease. Conditioning Treatments to prepare patients for stem cell transplantation. May include chemotherapy, monoclonal antibody therapy and radiation. The treatments used to prepare a patient for stem cell transplantation (a procedure in which a person receives blood stem cells, which make any type of blood cell). A conditioning regimen may include chemotherapy, monoclonal antibody therapy and radiation to the entire body. It helps make room in the patient’s bone marrow for new blood stem cells to grow; prevent the patient's body from rejecting the transplanted cells; and kill any cancer cells that are in the body.

Support for transplant patients and their families

We have extensive experience supporting patients and families before, during and after transplant with resources such as housing options, school and childcare, caregiver training and support and help with financial arrangements and insurance.

Learn more about transition services at SCCA

Long-term transplant follow-up

We've found partnering with referring doctors and staying connected about our shared patients' leads to the best long-term results. SCCA’s Long-Term Follow-Up Program for transplant recipients is unmatched. Our highly trained transplant specialists provide lifelong services—including telephone consultations and direct care—to patients and their doctors to prevent, manage and treat late effects and graft-versus-host-disease and consider alternatives for those whose disease recurs.

Long-Term Follow-Up Program

The future of transplantation is here

Fred Hutch teams first developed clinical use of bone marrow transplants more than 40 years ago, under the direction of E. Donnall Thomas, MD, who won a Nobel Prize for his groundbreaking work.

Today, we are advancing the use of stem cell transplantation for a broader array of diseases — not only leukemia, Hodgkin and non-Hodgkin lymphoma, and multiple myeloma, but also other cancers, bone marrow deficiencies, inborn errors of metabolism and immune disorders.

Learn more about our transplant program.

Bone marrow The soft, spongy material in the center of your bones that produces all your blood cells, such as white blood cells, red blood cells and platelets. Stem cell A cell from which other types of cells develop. For example, blood cells develop from blood-forming stem cells.

Information for your transplant patients

Preparing for Transplant is an extensive guide that will help your patients and their families plan and prepare for getting a transplant at SCCA. The guide, a PDF document that you can download and print for your patients, covers:

Basics of transplantation
Seven steps of getting a transplant
Information for caregivers
Resources that are available to patients and their families while at SCCA
Maps for getting to SCCA

Resources

Preparing for Transplant

SCCA has detailed guides for transplant patients and their caregivers.

Download Guide

Preparing for Transplant

Meet our experts

With over 50 hematology and transplant experts, the Fred Hutch BMT Program at SCCA is one of the top transplant programs in the country.

View Providers

Back To: Refer A Patient